Oncopeptides announces J-code J9247 for Pepaxto® (melphalan flufenamide) injection, 1mg. This J-code will be effective on October 1, 2021.
An at-home option for cervical cancer screening breaks down barriers to care and offers the same level of precision as screening in the clinic.
